Company profile: AlliedPath
1.1 - Company Overview
Company description
- Provider of cancer-focused molecular diagnostics testing, offering an extensive menu of high-quality, solid tumor specific molecular tests to regional hospital and reference laboratories, with test results combined with expert pathology analysis into an easy-to-interpret patient report.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AlliedPath
Helomics
HQ: United States
Website
- Description: Provider of comprehensive, personalized tumor profiling for oncology, utilizing proprietary tissue-based live-cell and fixed-cell laboratory platforms to deliver next-generation diagnostics aimed at improving patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helomics company profile →
GeneLink
HQ: United States
Website
- Description: Provider of genetic profile development, product development, business development, and support services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneLink company profile →
NEO New Oncology
HQ: Germany
Website
- Description: Provider of the NEO diagnostic platform, designed and developed by NEO New Oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NEO New Oncology company profile →
Lantern Pharma
HQ: United States
Website
- Description: Provider of AI, machine learning, and genomics-enabled precision oncology therapies, offering RADR, an AI/ML platform to accelerate cancer drug development, and drug candidates including LP-300 (Phase 2 for relapsed advanced primary lung adenocarcinoma in never smokers), LP-184 (anticancer activity in solid tumors with homologous recombination deficiency), LP-284 (preclinical in non-Hodgkin’s lymphoma and DNA repair-deficient cells), Irofulven, and Dimensa to reduce chemotherapeutic toxicity and treat taxane-induced neuropathies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lantern Pharma company profile →
Fluxion Biosciences
HQ: United States
Website
- Description: Provider of cellular analysis tools and drug discovery applications, built on a proprietary microfluidic platform enabling precise cellular manipulation, low-volume compound addition, environmental control, and software-based data acquisition. Offerings include BioFlux Systems, IonFlux Mercury Systems, CellRaft AIR System, CERO 3D Incubator & Bioreactor, CASY Cell Counter & Analyzer, and TIGR Tissue Grinder and Dissociator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluxion Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AlliedPath
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AlliedPath
2.2 - Growth funds investing in similar companies to AlliedPath
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AlliedPath
4.2 - Public trading comparable groups for AlliedPath
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →